Gene · 9211
Papers3,019
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,019
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Anti-LGI1 encephalitis during FcRn inhibition with efgartigimod for myasthenia gravis: implications for the limitations of IgG recycling blockade. | Front Immunol | 2026 | 42233017 | PubTator, text mining | PubMed |
| Post-COVID-19 Leucine-Rich Glioma Inactivated 1 Autoimmune Limbic Encephalitis in an Aviator. | Aerosp Med Hum Perform | 2026 | 42229902 | PubTator, text mining | PubMed |
| Middle-aged predominance and diagnostic delays in anti-LGI1 encephalitis: the role of antibody testing. | Front Neurol | 2026 | 42222540 | PubTator, text mining | PubMed |
| Gene burden meta-analysis of 748 879 individuals identifies LGI1-ADAM23 protein complex association with epilepsy. | Epilepsia | 2026 | 42216960 | PubTator, text mining | PubMed |
| Is faciobrachial dystonic seizure a misnomer? A case report of atypical leg-predominant tonic-dystonic attacks in LGI1-associated encephalitis. | BMC Neurol | 2026 | 42216157 | PubTator, text mining | PubMed |
| Successful treatment of anti-LGI1-associated autoimmune encephalitis with efgartigimod: A case report and literature review. | Medicine (Baltimore) | 2026 | 42152296 | PubTator, text mining | PubMed |
| Child Neurology: Expanding the LGI1 Spectrum: Homozygous Loss-of-Function Variant in an Infant With Epileptic Encephalopathy. | Neurology | 2026 | 42150140 | PubTator, text mining | PubMed |
| The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons. | Proc Natl Acad Sci U S A | 2026 | 42150081 | PubTator, text mining | PubMed |
| [Anti-leucine-rich glioma-inactivated 1 antibody-positive encephalitis with a poor response to corticosteroids 2 months after onset of impaired memory: a case report]. | Rinsho Shinkeigaku | 2026 | 42144340 | PubTator, text mining | PubMed |
| Neuroinflammation and Mental Health in Multiple Sclerosis and Autoimmune Encephalitis: Bridging Biological Mechanisms and Psychosocial Factors. | Arch Intern Med Res | 2026 | 42137043 | PubTator, text mining | PubMed |
| Response to letter to the editor on "Long-term cognitive outcomes and persistent executive dysfunction in LGI1 autoimmune encephalitis". | J Neurol Sci | 2026 | 42127567 | PubTator, text mining | PubMed |
| Muscle Stiffness due to Neuromuscular Hyperexcitability. | Muscle Nerve | 2026 | 42124386 | PubTator, text mining | PubMed |
| Persistent Executive Dysfunction Despite Global Cognitive Improvement in LGI1 Autoimmune Encephalitis. | J Neurol Sci | 2026 | 42114313 | PubTator, text mining | PubMed |
| A case of autoimmune encephalitis with autoimmune gastritis presenting as refractory hyponatremia. | BMC Neurol | 2026 | 42087100 | PubTator, text mining | PubMed |
| The cascade to pathogenicity in autoantibody-mediated CNS diseases. | Brain | 2026 | 42081370 | PubTator, text mining | PubMed |
| [Rapidly progressive cognitive impairment as a single clinical manifestation of anti-NMDA receptor encephalitis]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2026 | 42054334 | PubTator, text mining | PubMed |
| Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti-LGI1 Encephalitis. | Ann Clin Transl Neurol | 2026 | 42033172 | PubTator, text mining | PubMed |
| Preliminary observations on the efficacy of efgartigimod in anti-LGI1-associated autoimmune encephalitis. | Ther Adv Neurol Disord | 2026 | 42027694 | PubTator, text mining | PubMed |
| Screening for serum antineuronal antibodies in pediatric epilepsy. | Brain Dev | 2026 | 42025277 | PubTator, text mining | PubMed |
| Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes. | Curr Opin Neurol | 2026 | 42007814 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9211/papers?page=3